NASDAQ: CROXCrocs Inc Stock
$96.42+0.32 (+0.33%)
Updated Apr 30, 2025
CROX Price
$96.42
Fair Value Price
N/A
Market Cap
$5.40B
52 Week Low
$86.11
52 Week High
$165.32
P/E
6.03x
P/B
2.94x
P/S
1.59x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.10B
Earnings
$950.07M
Gross Margin
58.8%
Operating Margin
24.86%
Profit Margin
23.2%
Debt to Equity
1.62
Operating Cash Flow
$992M
Beta
1.6
Next Earnings
May 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CROX Overview
Crocs, Inc., together with its subsidiaries, designs, develops, manufactures, markets, and distributes casual lifestyle footwear and accessories for men, women, and children. It offers various footwear products, including clogs, sandals, slides, flip-flops, boots, flats, wedges, platforms, socks, shoe charms, loafers, sneakers, and slippers under the Crocs brand name. The company sells its products in approximately 85 countries through wholesalers, retail stores, e-commerce sites, and third-party marketplaces. As of December 31, 2021, it had 193 outlet stores, 107 retail stores, 373 company-operated stores, 73 kiosks and store-in-stores, and 14 company-operated e-commerce sites. The company serves in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Crocs, Inc. was founded in 1999 and is headquartered in Broomfield, Colorado.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CROX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shoe
Industry Rating
C
CROX
Ranked#4 of 13
Ranked#4 of 13
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $29.90 | B | |
| $21.39 | B | |
| $13.05 | B |
Be the first to know about important CROX news, forecast changes, insider trades & much more!
CROX News
Overview
Due Diligence Score
–
Industry Average (40)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CROX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CROX is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CROX is good value based on its earnings relative to its share price (6.03x), compared to the US market average (29.18x)
P/E vs Market Valuation
CROX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CROX due diligence checks available for Premium users.
Valuation
CROX fair value
Fair Value of CROX stock based on Discounted Cash Flow (DCF)
Price
$96.42
Fair Value
$336.44
Undervalued by
71.34%
CROX is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CROX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.03x
Industry
23.48x
Market
29.18x
CROX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CROX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CROX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.94x
Industry
4.82x
CROX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CROX's financial health
Profit margin
Revenue
$989.8M
Net Income
$368.9M
Profit Margin
37.3%
CROX's Earnings (EBIT) of $1.02B... subscribe to Premium to read more.
Interest Coverage Financials
CROX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.8B
Liabilities
$3.0B
Debt to equity
1.62
CROX's short-term assets ($872.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CROX's long-term liabilities ($2.24B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CROX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CROX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$321.9M
Investing
-$18.5M
Financing
-$302.4M
CROX's operating cash flow ($992.49M)... subscribe to Premium to read more.
Debt Coverage Financials
CROX vs Shoe Stocks
Crocs Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.